Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management, by Min e al
https://t.co/sme922DgaX
MUY IMPORTANTE: En el Hospital 12 de Octubre acabamos de abrir el reclutamiento para el primer ensayo clínico con 177Lu-DOTATATE para MENINGIOMAS RECURRENTES. Es una patología donde apenas hay investigación farmacológica y esta es una gran oportunidad de nuevo tratamiento.
💡 ¿Eres R0 y estás buscando tu hospital ideal?
🧠 ¿Acabas de hacer el MIR y Neurología es una de tus opciones de especialidad?
Desde el Servicio de Neurología del Hospital General Universitario Gregorio Marañón os presentamos nuestro vídeo oficial 📺
https://t.co/iZzQ4c9LTU
The diagnostic criteria of CIDP is not simple.
Trying to make it easier, our @MayoClinicNeuro PN group lead by @grace_swart , Mike Skolka and Chris Klein created the CIDP calculator. It’s open access and If the probability of CIDP is >= 92% the sensitivity and specificity for CIDP is 100% and 93%, respectively, after exclusion of the most common mimics.
https://t.co/emThZiCk5o
Transthyretin amyloidosis is a progressive, fatal disease that often leads to cardiomyopathy. Research findings on vutrisiran for patients with transthyretin amyloidosis with cardiomyopathy are summarized in a new Quick Take video. https://t.co/9cHz7h3wXS
New McDonald Criteria for diagnosis MS. @XMontalban: New criteria includes RIS under certain circumstances, central vein sign, neurofilament light chain and optic nerve. #ECTRIMS2024
Highlighting this paper again….
One of the Best Papers from Parkinsonism & Related Disorders
Towards a biological diagnosis of PD
https://t.co/sy7rYxq7Kv
@PRDAssociation